Evidence map›Paper›PMID 41708789›Full record

ArticleScientific reports2026

An automated image analysis pipeline for wide-field optical redox imaging of patient-derived cancer organoids.

Angela Hsu, Kayvan Samimi, Amani A Gillette, Shirsa Udgata, Alexa E Schmitz, Wenxuan Zhao, Dustin A Deming, Melissa C Skala

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angela HsuCellular and Molecular Pathology Program, University of Wisconsin, Madison, WI, USA.
Kayvan SamimiMorgridge Institute for Research, Madison, WI, USA.
Amani A GilletteMorgridge Institute for Research, Madison, WI, USA.
Shirsa UdgataMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin, Madison, WI, USA.
Alexa E SchmitzMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin, Madison, WI, USA.
Wenxuan ZhaoMorgridge Institute for Research, Madison, WI, USA.
Dustin A DemingMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin, Madison, WI, USA.
Melissa C SkalaMorgridge Institute for Research, Madison, WI, USA. mcskala@wisc.edu.

Funding

RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
Optical imaging to predict cell-level genetic heterogeneity and treatment sensitivity in colorectal cancerR37CA226526 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DEMING, DUSTIN A · 2018 to 2024
$4.2M
Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoidsR01CA272855 · NCI · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI Dustin A Deming, Melissa Caroline Skala · 2023 to 2026
$3.1M
Label-free imaging of CAR T cell metabolismR01CA278051 · NCI · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI Christian Capitini, Krishanu Saha · 2023 to 2026
$2.6M
Label-free single-cell imaging for quality control of cardiomyocyte biomanufacturingR01HL165726 · NHLBI · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI Sean P Palecek, Melissa Caroline Skala · 2023 to 2026
$2.5M
NCI NIH HHS R01 CA272855NCI NIH HHS R01 CA278051NHLBI NIH HHS R01 HL165726NHLBI NIH HHS T32 HL007899NIGMS NIH HHS T32 GM140935NIH HHS R01 CA278051NIH HHS R37 CA226526NIH HHS T32 HL07899
6 · The paper itself

Abstract

Wide-field optical redox imaging provides a fast and accessible method to monitor metabolic changes in cells and has recently been developed for drug screening in patient-derived cancer organoids (PDCOs). However, manual analysis of wide-field optical redox images is inefficient and laborious for large-scale drug screens. Here, we developed an automated pipeline for PDCO segmentation, single-PDCO tracking, and background correction in autofluorescence images. This pipeline was tested on two imaging systems over a 3-day time-course with two drug doses to demonstrate generalizability across imaging systems. Segmentation was performed using a fine-tuned Cellpose 3 model, which when compared to manual masks, outperformed Cellpose-SAM (4) and achieved high dice and recall scores across systems, indicating high reproducibility. Automated single-PDCO tracking was compared to manual tracking and the accuracy of the tracking algorithm exceeded 94% by two metrics, recall and Jaccard index. For background correction, the automated pipeline uses the full field-of-view to reduce sampling bias. Compared to the manual analysis pipeline, the automated pipeline resolves single-PDCO responses with comparable sensitivity to drug treatment but with over 127× faster processing time. This novel automated image analysis pipeline improves throughput and robustness in PDCO image analysis, which increases the accessibility and scalability of wide-field optical redox imaging for PDCO drug screening.

Indexed as

Image Processing, Computer-AssistedNeoplasmsOptical ImagingOrganoidsAlgorithmsAutomationHumansOxidation-ReductionReproducibility of Results

Identifiers

PMID41708789
PMCPMC13013648

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.